Description
Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.
Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date
Date | Announcements |
---|---|
September 25, 2023 | Application for quotation of securities - FPH |
September 25, 2023 | FPHs Donal ODwyer to retire, Graham McLean appointed |
September 25, 2023 | Ongoing Disclosure Document |
September 25, 2023 | Notification of cessation of securities - FPH |
September 25, 2023 | Application for quotation of securities - FPH |
September 25, 2023 | Application for quotation of securities - FPH |
September 25, 2023 | Notice of Annual General Meeting/Proxy Form |
September 25, 2023 | Update - Dividend/Distribution - FPH |
September 25, 2023 | Application for quotation of securities - FPH |
September 25, 2023 | Notification of cessation of securities - FPH |
September 25, 2023 | Application for quotation of securities - FPH |
September 25, 2023 | FPH provides ASX CEO Connect presentation |
September 25, 2023 | Notification of closing date for Director nominations |
September 25, 2023 | FPH reminds shareholders of DRP, amends formula calculation |
September 25, 2023 | Ongoing Disclosure Notice |
September 25, 2023 | Preliminary Final Report |
September 25, 2023 | Dividend/Distribution - FPH |
September 25, 2023 | Becoming a substantial holder |
September 25, 2023 | Notification of cessation of securities - FPH |
September 25, 2023 | Application for quotation of securities - FPH |
Load More
Load Less
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EPS (Basic) | $ |
|
|
|
|
6.32 | 6.32 | 6.32 |
|
|
|
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Date | keys |
---|---|
08 March 2023 | Update on Indonesian subsidiary PT Bank Commonwealth Update on Indonesian subsidiary PT Bank Commonwealth |
09 March 2023 | ASB 2023 Half Year Financial Results Media Release |
RVN · NASDAQ
Rivian,Inc
AUD $60.14
-3.56 (-1.581%)
RVN · NASDAQ
Rivian,Inc
AUD $60.14
-3.56 (-1.581%)
RVN · NASDAQ
Rivian,Inc
AUD $60.14
-3.56 (-1.581%)
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.